CN1824205A - Medicine for treating chronic prostatitis and its preparation method - Google Patents
Medicine for treating chronic prostatitis and its preparation method Download PDFInfo
- Publication number
- CN1824205A CN1824205A CN 200510048232 CN200510048232A CN1824205A CN 1824205 A CN1824205 A CN 1824205A CN 200510048232 CN200510048232 CN 200510048232 CN 200510048232 A CN200510048232 A CN 200510048232A CN 1824205 A CN1824205 A CN 1824205A
- Authority
- CN
- China
- Prior art keywords
- herba
- parts
- medicine
- chronic prostatitis
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of capsule or tablet for treating chronic prostatitis is prepared from 16 Chinese-medicinal materials including wild chrysanthemum flower, dandelion herb, red sage root, red peony root, etc through immersing, decocting, extracting solution, granulating and loading in capsules or tabletting.
Description
Technical field
The present invention relates to the Chinese herbal medicine is the Chinese patent medicine of feedstock production, is a kind of medicine for the treatment of chronic prostatitis specifically.The invention still further relates to the preparation method of this medicine.
Background technology
Chronic prostatitis is the commonly encountered diseases of harm adult male health, and sickness rate is up to 35~45%.Clinical symptoms is usually expressed as dysuria, pain; General fatigue, lumbago, weakness of the lower extremities; Part patient's sexual function is low, seminal emission, premature ejaculation, sexual impotence; Or dizziness, insomnia, melancholy, state of an illness stubbornness, outbreak repeatedly, the course of disease was delayed and was occurred neurosis for a long time.Severe patient, or forfeiture sexual function, or forfeiture reproductive function, or forfeiture work physical ability.
At present the clinical treatment chronic prostatitis adopt that antibiotics is oral more, intramuscular injection, intravenously administrable, two capsule four cavities conduit pipe administrations, injection in the direct prostate of per rectum or perineum, or DC electronic imports, its therapeutic effect is unsatisfactory, and exist easy infringement testicular spermatogenic, cause cross infection, the unsafe problem of complicated operation.With the Chinese herbal medicine is the Chinese patent medicine that raw material is produced, extensive because of its raw material sources, produces and easy to use, and has no side effect, and is more and more used.But the Chinese patent medicine that is used for the treatment of chronic prostatitis at present, as QIANLIEKANG PIAN, QIANLIEXIN JIAONANG etc., its clinical therapeutic efficacy can't be satisfactory.The recent discloseder successively Chinese patent medicine that is used for the treatment of chronic prostatitis, its clinical therapeutic efficacy is not confirmed as yet.
Summary of the invention
The object of the present invention is to provide and a kind ofly can effectively treat the chronic prostatitis disease, safe and convenient to use, the medicine that has no side effect.The present invention also aims to provide a kind of preparation method of this medicine.
The medicine that the present invention treats chronic prostatitis is the medicament of being made by following materials based on weight:
Cortex Phellodendri 5-15 part, Flos Chrysanthemi Indici 5-15 part, Herba Patriniae 5-15 part, Rhizoma Smilacis Glabrae 5-20 part, Herba Portulacae 5-15 part, Herba Taraxaci 5-15 part, Herba Houttuyniae 5-15 part, Bi 5-15 part, Herba Verbenae 5-15 part, Radix Salviae Miltiorrhizae 5-20 part, Radix Paeoniae Rubra 5-15 part, Poria 5-15 part, Rhizoma Alismatis 5-15 part, Herba Plantaginis 5-15 part, Radix Glycyrrhizae 5-15 part, Fructus Forsythiae 5-15 part.
The formula optimization weight proportion scope of preparation medicine of the present invention is:
Cortex Phellodendri 8-15 part, Flos Chrysanthemi Indici 8-15 part, Herba Patriniae 8-15 part, Rhizoma Smilacis Glabrae 8-20 part, Herba Portulacae 8-15 part, Herba Taraxaci 8-15 part, Herba Houttuyniae 8-15 part, Bi 8-15 part, Herba Verbenae 8-15 part, Radix Salviae Miltiorrhizae 8-20 part, Radix Paeoniae Rubra 8-15 part, Poria 8-15 part, Rhizoma Alismatis 8-15 part, Herba Plantaginis 8-15 part, Radix Glycyrrhizae 8-15 part, Fructus Forsythiae 8-15 part.
The optimum weight proportioning of medicine of the present invention is:
10 parts of Cortex Phellodendris, 10 parts of Flos Chrysanthemi Indicis, 10 parts of Herba Patriniaes, 12 parts of Rhizoma Smilacis Glabraes, 10 parts of Herba Portulacaes, 10 parts of Herba Taraxacis, 10 parts of Herba Houttuyniae, 10 parts of Bi , 10 parts of Herba Verbenae, 12 parts of Radix Salviae Miltiorrhizaes, 10 parts of Radix Paeoniae Rubra, 10 parts in Poria, 10 parts of Rhizoma Alismatis, 10 parts of Herba Plantaginiss, 10 parts in Radix Glycyrrhizae, 10 parts of Fructus Forsythiaes.
The preparation method of medicine of the present invention is:
(1) getting described raw material was soaked in water 6~8 hours;
(2) soak decocted 1~1.5 hour together with raw material, decocted with water 1~1.5 once more after getting filtrate, merged twice decoction filtrate and was condensed into thick paste;
(3) thick paste is dissolved in 75% ethanol, gets supernatant, reclaim ethanol, extractum system granule;
(4) granule divides encapsulated or tabletting and icing in 50~55 ℃ of oven dry, promptly makes the medicine that the present invention treats chronic prostatitis.
The present invention reaches clinical experience for many years in conjunction with modern medicines research achievement, from motherland's medicine treasure-house, filter out relevant heat-clearing and toxic substances removing, activating blood circulation to dissipate blood stasis, the Chinese herbal medicine that inducing diuresis and reducing edema effect is good, comprehensive its Chinese medicine pharmacopeia effect, and make its kind and dosage reach ideal tensile strength and form.For reaching, gram negative bacteria produce effects is arranged to the genitourinary system chronic inflammatory disease is common as Cortex Phellodendri, Flos Chrysanthemi Indici, Herba Patriniae, Rhizoma Smilacis Glabrae, Herba Portulacae, Herba Houttuyniae, Herba Verbenae according to pathogen infection, Fructus Forsythiae, Herba Taraxaci, Bi in addition, making it to become the effect of various plants antibiotic capacity reaches continuous and effective drug resistance does not take place, Radix Salviae Miltiorrhizae, the Radix Paeoniae Rubra of using activating blood circulation to dissipate blood stasis improve local blood circulation, promote the absorption recovery from illness of patients with chronic prostatitis (especially aseptic person) chronic inflammatory disease.
The medicine that the present invention treats chronic prostatitis has following advantage:
1, be raw material with the homologous natural plants of medicated diet, each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment chronic prostatitis of each Chinese herbal medicine, and is nontoxic to human body;
2, raw material sources are extensive, and cost of drugs is low, and applying clinical is convenient;
3, evident in efficacy.
Clinical drug of the present invention uses the result to show:
After taking medicine continuously 10, all sexual function have lowly, premature ejaculation, sexual impotence person are improved obviously or recover normal.All have chronic gastritis symptoms such as upper abdominal pain, belch, a dyspepsia person more for many years, can be clearly better or transference cure.
After taking medicine continuously 20, occur together epididymitis, seminal vesiculitis, chronic tunica vaginalis of spermatic cord inflammation person, when touching with hands, original enclosed mass or pain can be improved, alleviate or disappear, semen volume can increase, original urine is waited for, the urine meaning not to the utmost, urgent micturition, frequent micturition and the smooth phenomenon of urinating alleviate or disappear.
Along with constantly taking medicine, after 30 days, examination of prostatic fluid, original pathology composition alleviates, and perhaps recovers normal fully, and 84.5% patient reaches the clinical cure standard.
The specific embodiment
Take by weighing raw material by following counterweight:
10 kilograms of Cortex Phellodendris, 10 kilograms of Flos Chrysanthemi Indicis, 10 kilograms of Herba Patriniaes, 12 kilograms of Rhizoma Smilacis Glabraes, 10 kilograms of Herba Portulacaes, 10 kilograms of Herba Taraxacis, 10 kilograms of Herba Houttuyniae, 10 kilograms of Bi , 10 kilograms of Herba Verbenae, 12 kilograms of Radix Salviae Miltiorrhizaes, 10 kilograms of Radix Paeoniae Rubra, 10 kilograms in Poria, 10 kilograms of Rhizoma Alismatis, 10 kilograms of Herba Plantaginiss, 10 kilograms in Radix Glycyrrhizae, 10 kilograms of Fructus Forsythiaes.
Concrete preparation method:
Getting above-mentioned each raw material was soaked in water 6 hours; Afterwards, soak was decocted 1.5 hours together with raw material, decoct with water 1 hour once more after getting filtrate, merges twice decoction filtrate and make thick paste; Thick paste is dissolved in 75% ethanol, gets supernatant, reclaim ethanol, extractum system granule; Granule divides encapsulated or tabletting and icing in 50 ℃ of oven dry then.Promptly make the medicine of treatment chronic prostatitis of the present invention.
Claims (5)
1, a kind of medicine for the treatment of chronic prostatitis is characterized in that it is the medicament of being made by following materials based on weight:
Cortex Phellodendri 5-15 part, Flos Chrysanthemi Indici 5-15 part, Herba Patriniae 5-15 part, Rhizoma Smilacis Glabrae 5-20 part, Herba Portulacae 5-15 part, Herba Taraxaci 5-15 part, Herba Houttuyniae 5-15 part, BIBI 5-15 part, Herba Verbenae 5-15 part, Radix Salviae Miltiorrhizae 5-20 part, Radix Paeoniae Rubra 5-15 part, Poria 5-15 part, Rhizoma Alismatis 5-15 part, Herba Plantaginis 5-15 part, Radix Glycyrrhizae 5-15 part, Fructus Forsythiae 5-15 part.
2, the medicine of treatment chronic prostatitis according to claim 1 is characterized in that it is the medicament of being made by following materials based on weight:
Cortex Phellodendri 8-15 part, Flos Chrysanthemi Indici 8-15 part, Herba Patriniae 8-15 part, Rhizoma Smilacis Glabrae 8-20 part, Herba Portulacae 8-15 part, Herba Taraxaci 8-15 part, Herba Houttuyniae 8-15 part, BIBI 8-15 part, Herba Verbenae 8-15 part, Radix Salviae Miltiorrhizae 8-20 part, Radix Paeoniae Rubra 8-15 part, Poria 8-15 part, Rhizoma Alismatis 8-15 part, Herba Plantaginis 8-15 part, Radix Glycyrrhizae 8-15 part, Fructus Forsythiae 8-15 part.
3, the medicine of treatment chronic prostatitis according to claim 1 is characterized in that it is the medicament of being made by following materials based on weight:
10 parts of Cortex Phellodendris, 10 parts of Flos Chrysanthemi Indicis, 10 parts of Herba Patriniaes, 12 parts of Rhizoma Smilacis Glabraes, 10 parts of Herba Portulacaes, 10 parts of Herba Taraxacis, 10 parts of Herba Houttuyniae, 10 parts of BIBI, 10 parts of Herba Verbenae, 12 parts of Radix Salviae Miltiorrhizaes, 10 parts of Radix Paeoniae Rubra, 10 parts in Poria, 10 parts of Rhizoma Alismatis, 10 parts of Herba Plantaginiss, 10 parts in Radix Glycyrrhizae, 10 parts of Fructus Forsythiaes.
4, according to the medicine of claim 1,2 or 3 described treatment chronic prostatitiss, its feature is capsule or tablet in described medicament.
5, the preparation method of the medicine of treatment chronic prostatitis according to claim 4 is characterized in that:
(1) getting described raw material was soaked in water 6~8 hours;
(2) soak decocted 1~1.5 hour together with raw material, decocted with water 1~1.5 once more after getting filtrate, merged twice decoction filtrate and was condensed into thick paste;
(3) thick paste is dissolved in 75% ethanol, gets supernatant, reclaim ethanol, extractum system granule;
(4) granule divides encapsulated or tabletting and icing in 50~55 ℃ of oven dry.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100482325A CN1824205B (en) | 2005-12-22 | 2005-12-22 | Medicine for treating chronic prostatitis and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100482325A CN1824205B (en) | 2005-12-22 | 2005-12-22 | Medicine for treating chronic prostatitis and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1824205A true CN1824205A (en) | 2006-08-30 |
CN1824205B CN1824205B (en) | 2010-04-28 |
Family
ID=36935149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005100482325A Expired - Fee Related CN1824205B (en) | 2005-12-22 | 2005-12-22 | Medicine for treating chronic prostatitis and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1824205B (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100417402C (en) * | 2006-09-08 | 2008-09-10 | 王广宇 | Liposoluble traditional medicine bougie for treating acute and chronic prostatitis, and manufacturing technique thereof |
CN101912477A (en) * | 2010-08-02 | 2010-12-15 | 吴宝国 | Health-care tea |
CN102370776A (en) * | 2011-11-17 | 2012-03-14 | 中国中医科学院中医临床基础医学研究所 | Chinese medicinal compound preparation for treating prostatitis and preparation method thereof |
CN101569731B (en) * | 2008-04-30 | 2012-09-12 | 王宪成 | Traditional Chinese medicine for treating chronic prostatitis |
CN103656435A (en) * | 2013-12-19 | 2014-03-26 | 青岛中科菲力工程技术研发有限公司 | Traditional Chinese medicine capsule for treating prostatitis and preparation method of capsule |
CN105056028A (en) * | 2015-08-06 | 2015-11-18 | 苏州神林堂中医药研究所 | Drug for treatment of chronic prostatitis |
CN105148123A (en) * | 2015-07-25 | 2015-12-16 | 王军 | Traditional Chinese medicinal composition for treating prostatitis |
CN105998955A (en) * | 2016-06-27 | 2016-10-12 | 贵定廖氏古方科技有限公司 | Traditional Chinese medicine preparation for treating male prostate diseases and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1235621C (en) * | 2002-11-29 | 2006-01-11 | 咸阳步长制药有限公司 | Medicine composition for treating prostate proliferation, and its prepn. method |
CN100431574C (en) * | 2004-11-15 | 2008-11-12 | 长春海外制药集团有限公司 | Capsule for treating prostate disease and its preparing process |
-
2005
- 2005-12-22 CN CN2005100482325A patent/CN1824205B/en not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100417402C (en) * | 2006-09-08 | 2008-09-10 | 王广宇 | Liposoluble traditional medicine bougie for treating acute and chronic prostatitis, and manufacturing technique thereof |
CN101569731B (en) * | 2008-04-30 | 2012-09-12 | 王宪成 | Traditional Chinese medicine for treating chronic prostatitis |
CN101912477A (en) * | 2010-08-02 | 2010-12-15 | 吴宝国 | Health-care tea |
CN101912477B (en) * | 2010-08-02 | 2011-11-09 | 吴宝国 | Health-care tea |
CN102370776A (en) * | 2011-11-17 | 2012-03-14 | 中国中医科学院中医临床基础医学研究所 | Chinese medicinal compound preparation for treating prostatitis and preparation method thereof |
CN103656435A (en) * | 2013-12-19 | 2014-03-26 | 青岛中科菲力工程技术研发有限公司 | Traditional Chinese medicine capsule for treating prostatitis and preparation method of capsule |
CN105148123A (en) * | 2015-07-25 | 2015-12-16 | 王军 | Traditional Chinese medicinal composition for treating prostatitis |
CN105056028A (en) * | 2015-08-06 | 2015-11-18 | 苏州神林堂中医药研究所 | Drug for treatment of chronic prostatitis |
CN105998955A (en) * | 2016-06-27 | 2016-10-12 | 贵定廖氏古方科技有限公司 | Traditional Chinese medicine preparation for treating male prostate diseases and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1824205B (en) | 2010-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1169541C (en) | Medicine for treating rheumatoid arthritis | |
CN1824205B (en) | Medicine for treating chronic prostatitis and its preparation method | |
CN1060960C (en) | Health-care wine with antisenility function | |
CN1375298A (en) | Pain-relieving notoginseng mixture | |
CN101028441A (en) | Energy-supplemented liquid health-care medicinal liquor | |
CN1390585A (en) | Chinese medicine for detoxication purpose and its preparing process | |
CN103908602A (en) | Gynecological nursing liquid and preparation method thereof | |
CN1517119A (en) | Medicinal wine or liquid for treating cold | |
CN1657067A (en) | Chinese medicine for treating psoriasis | |
CN1899518A (en) | External use Chinese medicine for treating burn and scold and its preparing method | |
CN1251736C (en) | Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method | |
CN1057230C (en) | Traditional Chinese medicine capsule for treating thrombophlebitis | |
CN1285354C (en) | Medicine for treating cerebral infarction | |
CN1686210A (en) | Traditional Chinese medicinal preparation for treating hepatitis B | |
CN1164294C (en) | Liver cancer resisting medicine | |
CN1051468C (en) | Capsule for curing rheumatism | |
CN1190215C (en) | Chinese medicine for treating rheumatism | |
CN1244367C (en) | 'Dianjian' liqid for curing epilepsy sickness | |
CN1244370C (en) | Medicinal composition for curing skin disease | |
CN1168482C (en) | Chinese medicine composition for treating enteritis | |
CN1342478A (en) | Medical wine for treating rheumatism | |
CN1277577C (en) | Chinese traditional medicine for treating cerebral thrombosis, preparation method and application | |
CN101406587B (en) | Oral medicament for treating hemorrhoid | |
CN1380082A (en) | Chinese medicine for curing female chronic inflammation | |
CN1235840A (en) | Chinese medicine powder for curing rheumatoid and rheumatic diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100428 Termination date: 20111222 |